Chronic Obstructive Airway Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.
|
22693272 |
2012 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Nrf2 expression was lower in COPD patients than in control subjects.
|
26861788 |
2016 |
Chronic Obstructive Airway Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
NFE2L2 (rs35652124), PRNP (rs1799990), and HSPA1A (rs1008438) were significantly associated with COPD only in smokers.
|
30641209 |
2019 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Nuclear factor-erythroid 2-related factor 2 (Nrf2) has been regarded to be a promising therapeutic target for COPD.
|
31760092 |
2019 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Agonists of the cytoprotective transcription factor Nrf2 (sulforaphane and compound 7) reverse defects in phagocytosis of S. pneumoniae and nontypeable Haemophilus influenzae by COPD AMs.
|
29547002 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Based on these findings, BML-111 may prevent NLRP3 inflammasome activation and inhibit ROS production via upregulation of Nrf-2, thereby exerting an anti-inflammatory effect on COPD model mice.
|
30102962 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Because Nrf2 failure significantly contributes to the development of COPD, our findings suggest that the possibility to prevent Nrf2 reduction may open a new scenario in helping to prevent the oxidative stress-associated lung function decline.
|
27555763 |
2016 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Bronchial epithelium is the most responsive tissue for transcriptional activation of Nrf2 target genes in active smokers compared to former-smokers with COPD that correlated with oxidative stress and inflammatory markers.
|
31429757 |
2019 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Exercise Ameliorates Emphysema Of Cigarette Smoke-Induced COPD In Mice Through The Exercise-Irisin-Nrf2 Axis.
|
31814716 |
2019 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, monocyte-derived macrophages obtained from healthy volunteers (non-smokers and smokers) and COPD patients showed a significant correlation between HDAC2 expression and Nrf2 expression (r=0.92, p<0.0001).
|
21320471 |
2011 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
LHGDN |
Furthermore, the Nrf2 mRNA level was decreased in laser capture microdissection-retrieved macrophages obtained from subjects with COPD (n = 10) compared with control subjects (n = 10) (P = 0.001).
|
18566336 |
2008 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the Nrf2 mRNA level was decreased in laser capture microdissection-retrieved macrophages obtained from subjects with COPD (n = 10) compared with control subjects (n = 10) (P = 0.001).
|
18566336 |
2008 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Hence, NRF2 targeting might provide clinical benefit by reducing both oxidative stress and inflammation in COPD.
|
21459041 |
2011 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
In conclusion, Nrf2 mediates the protective effects of both Wnt3a/β-catenin and AMPK on lung inflammatory responses during the development of COPD/emphysema.
|
29659176 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
In conclusion, ILG protected against CS-induced COPD by inhibiting inflammatory and oxidative stress via the regulation of the Nrf2 and NF-κB signaling pathways.
|
30294270 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Noncovalent inhibitors of the Keap1-Nrf2 protein-protein interaction (PPI) have therapeutic potential in a range of disease states including neurodegenerative diseases (Parkinson's and Alzheimer's diseases), chronic obstructive pulmonary disease and various inflammatory conditions.
|
29927029 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Nuclear erythroid-related factor 2 (Nrf2) regulates antioxidant defensive mechanism in COPD.
|
28347799 |
2017 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our findings demonstrate the importance of Nrf2 and its downstream target MARCO in improving antibacterial defenses and provide a rationale for targeting this pathway, via pharmacological agents such as sulforaphane, to prevent exacerbations of COPD caused by bacterial infection.
|
21490276 |
2011 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our results indicate that aberrant DNA methylation is (1) a genome-wide phenomenon in small airways of patients with COPD, and (2) associated with altered expression of genes and pathways important to COPD, such as the NF-E2-related factor 2 oxidative response pathway.
|
24298892 |
2014 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Plasma Nrf2 and CRP levels significantly increased in a stepwise manner with an increase in inflammatory status (control vs. COPD-stable vs. COPD-exacerbation) (p = 0.002, p < 0.001).
|
29529843 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Presence of the LH or MM haplotype (hazard ratio, 3.36; 95% confidence interval, 1.16-9.69), gender (0.13; 0.02-0.67), and post-bronchodilator FEV1 value of predicted (0.95; 0.91-0.99) are significant predictors of respiratory failure development.The haplotype of the Nrf2 gene promoter affects its activity, and is associated with the severity and the development of respiratory failure in COPD.
|
20534903 |
2010 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Recuperating lung decoction attenuates inflammation and oxidation in cigarette smoke-induced COPD in rats via activation of ERK and Nrf2 pathways.
|
28749079 |
2017 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The Nrf2-antioxidant pathway has been shown to be important in the protection against various lung injuries including acute lung injury/acute respiratory distress syndrome and bronchopulmonary dysplasia, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, asthma, and allergy and was widely examined for new therapeutic targets.
|
27864288 |
2017 |
Chronic Obstructive Airway Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to investigate the protective role of crocin against CSE-mediated oxidative stress, inflammatory process, Nrf2 modifications and impairment of cardiac function in rats with COPD.
|
29631592 |
2018 |
Chronic Obstructive Airway Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The HO-1, NF-κB and 8-OHdG were found highly expressed in COPD rat lung, particularly at the higher PM<sub>2.5</sub> dose of cold stress groups, while Nrf2 was found declined.
|
29793105 |
2018 |